This expands the range of cancers that can be treated, including solid tumors, which are typically more challenging for CAR-T therapies. Patents in the field of TCR-T cell therapy include U.S. Patent No. 8,101,205, which covers TCR gene transfer technology, and U.S. Patent No. 9,546,083, which relates to methods for enhancing T-cell activity against tumor antigens. These patents are critical to protecting TCR's proprietary designs and methods. 2.3. NK Cell Therapy Natural Killer (NK) cells are a type of immune cell that has the innate ability to attack cancer cells.
NK cell therapies involve using donor NK cells or papua new guinea b2b leads enhancing the patient's own NK cells to better recognize and kill cancer cells. This approach is particularly promising for the treatment of solid tumors and metastatic cancers. Researchers are also exploring ways to combine NK cell therapy with other treatments, such as checkpoint inhibitors, to enhance their effectiveness. Important patents in NK cell therapy include U.S. Patent No. 8,956,632, which covers the expansion and activation of NK cells for therapeutic purposes, and Patent No. 2.4. Dendritic cell vaccines Dendritic cells are crucial for initiating immune responses.
Importance of Patent Due Diligence In the modern business environment, patents play a vital role in protecting intellectual property, fostering innovation, and providing competitive advantages. Conducting thorough patent due diligence is essential for a variety of reasons, each contributing to the strategic value and risk management of a company's patent portfolio. Table of Contents 1. Importance of Patent Due Diligence 2. Determining Value and Monetary Potential 3. Mitigating Violation Risks 4. Responding to Resignation and Retirement Notices 5. Efficiency in Patent Due Diligence 5.1. Define Goals and Prioritize Tasks 5.2.